Literature DB >> 22492856

Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.

Christina M Parrinello1, Elizabeth Sinclair, Alan L Landay, Nell Lurain, A Richey Sharrett, Stephen J Gange, Xiaonan Xue, Peter W Hunt, Steven G Deeks, Howard N Hodis, Robert C Kaplan.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) infection has been implicated in immune activation and accelerated progression of immunodeficiency from human immunodeficiency virus (HIV) coinfection. We hypothesized that CMV is associated with vascular disease in HIV-infected adults.
METHODS: In the Women's Interagency HIV Study, we studied 601 HIV-infected and 90 HIV-uninfected participants. We assessed the association of CMV immunoglobulin G (IgG) level with carotid artery intima-media thickness, carotid artery distensibility, Young's elastic modulus, and blood pressures. Multivariable models adjusted for age, race/ethnicity, smoking, diabetes, and body mass index.
RESULTS: Mean CMV IgG levels were higher in HIV-infected women compared with HIV-uninfected women (P < .01). Among HIV-infected women, higher CMV IgG level was associated with decreased carotid artery distensibility (P < .01) and increased Young's modulus (P = .02). Higher CMV IgG antibody level was associated with increased prevalence of carotid artery lesions among HIV-infected women who achieved HIV suppression on antiretroviral therapy, but not among viremic or untreated HIV-infected women. Adjustment for Epstein-Barr virus antibody levels and C-reactive protein levels had no effect on the associations between CMV IgG levels and vascular parameters.
CONCLUSIONS: Cytomegalovirus antibody titers are increased in HIV-infected women and associated with subclinical cardiovascular disease. Host responses to CMV may be abnormal in HIV infection and associated with clinical disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492856      PMCID: PMC3415890          DOI: 10.1093/infdis/jis276

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.

Authors:  Priscilla Y Hsue; Peter W Hunt; Elizabeth Sinclair; Barry Bredt; Arlana Franklin; Maudi Killian; Rebecca Hoh; Jeffrey N Martin; Joseph M McCune; David D Waters; Steven G Deeks
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Surgical experience with carotid stenosis in young HIV-1 positive patients under antiretroviral therapy: an emerging problem?

Authors:  G Regina; G Impedovo; D Angiletta; F Martiradonna; A Lillo; F Perilli; V Marotta; A Marzullo; G Epifani; J R Fiore; P Maggi
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-02       Impact factor: 7.069

4.  Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.

Authors:  Eric C Seaberg; Alvaro Muñoz; Ming Lu; Roger Detels; Joseph B Margolick; Sharon A Riddler; Carolyn M Williams; John P Phair
Journal:  AIDS       Date:  2005-06-10       Impact factor: 4.177

Review 5.  Effects of human cytomegalovirus infection on the coagulation system.

Authors:  Alessandro Squizzato; Victor E A Gerdes; Harry R Büller
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

Review 6.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

Review 7.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Authors:  Maher K Gandhi; Rajiv Khanna
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

8.  An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1.

Authors:  W J Waldman; D A Knight; E H Huang
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

9.  Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?

Authors:  Namik Kemal Eryol; Hüseyin Kiliç; Ali Gül; Ibrahim Ozdogru; Tugrul Inanç; Ali Dogan; Ramazan Topsakal; Emrullah Basar
Journal:  Int Heart J       Date:  2005-03       Impact factor: 1.862

10.  Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.

Authors:  F J Nieto; E Adam; P Sorlie; H Farzadegan; J L Melnick; G W Comstock; M Szklo
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more
  63 in total

Review 1.  HIV infection and immune activation: the role of coinfections.

Authors:  Afroditi Boulougoura; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 2.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 3.  Inflammation, immune activation, and cardiovascular disease in HIV.

Authors:  Eric Nou; Janet Lo; Steven K Grinspoon
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

4.  Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response.

Authors:  Kristine M Erlandson; Amanda A Allshouse; Eric Rapaport; Brent E Palmer; Cara C Wilson; Adriana Weinberg; Samantha MaWhinney; Thomas B Campbell
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-08       Impact factor: 2.205

Review 5.  Immunoactivation at the crossroads of human disease.

Authors:  Leonid Margolis
Journal:  Am J Med       Date:  2015-01-28       Impact factor: 4.965

6.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

Review 7.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

Review 8.  Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Luis Barcena; Randall Tressler
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

Review 9.  Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Authors:  Sara Gianella; Scott Letendre
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

Review 10.  Immune activation and cardiovascular disease in chronic HIV infection.

Authors:  Chris T Longenecker; Claire Sullivan; Jason V Baker
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.